Translations:SGLT2 inhibitor/6/en

Revision as of 19:46, 12 February 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Two reviews have concluded that SGLT2 inhibitors benefit patients with atherosclerotic major adverse cardiovascular events (MACE). One of those studies defined MACE as the composite of myocardial infarction, stroke, or cardiovascular death.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/6/en&oldid=113835"